HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Intestinal permeability in Crohn's disease and effects of elemental dietary therapy].

Abstract
Enteral intake of non-metabolic monosacharide and disaccharide, followed by measurement of the urinary excretion ratio of the two, is a method used to investigate intestinal permeability. L/R ratio (lactulose/1-rhamnose urinary excretion ratio) is considered an indicator of permeability of the small intestine. An increased L/R ratio is caused by mucosal disorders of the small intestine. The L/R ratio in all patients (n = 92) with Crohn's disease was 0.079 +/- 0.081 (mean +/- S.D.), which was significantly higher than the value in normal controls (0.027 +/- 0.009, n = 20, p < 0.05). In 39 patients with Crohn's disease, we assessed intestinal permeability before after treatment with an elemental diet, and during remission. The L/R ratio was 0.120 +/- 0.092, before treatment and 0.065 +/- 0.097 after treatment (p < 0.05), showing increased intestinal permeability before elemental dietary treatment. During remission, the L/R ratio was 0.035 +/- 0.028; this did not differ significantly from the value obtained after treatment. We conclude that intestinal permeability is useful for investigating disease activity in patients with Crohn's disease.
AuthorsM Iwata, H Nakano, Y Matsuura, M Nagasaka, M Misawa, S Mizuta, I Ito, T Saito, T Ito, M Hokama, M Kamiya, R Hobara, M Watanabe, K Takahama
JournalNihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology (Nihon Shokakibyo Gakkai Zasshi) Vol. 98 Issue 6 Pg. 636-43 (Jun 2001) ISSN: 0446-6586 [Print] Japan
PMID11436280 (Publication Type: Journal Article)
Chemical References
  • Gastrointestinal Agents
  • Lactulose
  • Rhamnose
Topics
  • Adolescent
  • Adult
  • Crohn Disease (diet therapy, metabolism)
  • Female
  • Food, Formulated
  • Gastrointestinal Agents (pharmacokinetics)
  • Humans
  • Intestinal Mucosa (metabolism)
  • Lactulose (pharmacokinetics)
  • Male
  • Middle Aged
  • Permeability
  • Rhamnose (pharmacokinetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: